Discover
PHAR
Pharming Group N.V.
12.23
1 x 11.30
1 x 12.21
bid
ask
+
0.88
7.75%
1 @ 04:00 PM
12.23 +0.00 (0.00%)
| Ytd | -30.79% | |
| 1y | 1.07% |
11.31
day range
12.33
9.62
52 week range
21.34
| Open | 11.46 | Prev Close | 11.35 | Low | 11.31 | High | 12.33 | Mkt Cap | 865.62M |
| Vol | 0.00 | Avg Vol | 10.30K | EPS | 0.16 | P/E | 76.44 | Forward P/E | 216.49 |
| Beta | 0.09 | Short Ratio | 0.38 | Inst. Own | 0.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 12.71 | 200-d Avg | 15.36 | 1yr Est | 34.35 |
| Income Statement | |||
| Total Revenue | 90.21M | ||
| Revenues (USD) | 102.51M | ||
| Cost of Revenue | 14.55M | ||
| Gross Profit | 75.67M | ||
| Operating Expenses | 74.36M | ||
| Research and Development Expense | 32.26M | ||
| Selling, General and Administrative Expense | 43.52M | ||
| Operating Income | 1.31M | ||
| Income Tax Expense | 1.40M | ||
| Net Income | 1.64M | ||
| Net Income Common Stock | 1.64M | ||
| Net Income Common Stock (USD) | 1.86M | ||
| Consolidated Income | 1.64M | ||
| Earnings per Basic Share | 0.02 | ||
| Earnings per Basic Share (USD) | 0.02 | ||
| Earnings per Diluted Share | 0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 3.04M | ||
| Earning Before Interest & Taxes (USD) | 3.45M | ||
| Weighted Average Shares | 701.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 158.28M | ||
| Cash and Equivalents (USD) | 179.86M | ||
| Investments | 9.80M | ||
| Investments Non-Current | 9.80M | ||
| Trade and Non-Trade Receivables | 56.98M | ||
| Current Assets | 280.69M | ||
| Property, Plant & Equipment Net | 20.48M | ||
| Total Assets | 467.98M | ||
| Debt Current | 9.05M | ||
| Total Debt | 113.30M | ||
| Current Liabilities | 93.25M | ||
| Debt Non-Current | 104.25M | ||
| Total Liabilities | 197.49M | ||
| Accumulated Retained Earnings (Deficit) | -278.24M | ||
| Shareholders Equity | 270.49M | ||
| Shareholders Equity (USD) | 307.38M | ||
| Assets Non-Current | 187.30M | ||
| Total Debt (USD) | 128.74M | ||
| Goodwill and Intangible Assets | 128.08M | ||
| Inventory | 65.43M | ||
| Liabilities Non-Current | 104.25M | ||
| Trade and Non-Trade Payables | 82.32M | ||
| Tax Assets | 28.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.04M | ||
| Net Cash Flow from Financing | -2.45M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.19M | ||
| Capital Expenditure | -83.00K | ||
| Issuance (Purchase) of Equity Shares | 1.22M | ||
| Issuance (Repayment) of Debt Securities | -3.67M | ||
| Net Cash Flow from Investing | -83.00K | ||
| Net Cash Flow from Operations | -9.66M | ||
| Share Based Compensation | 3.35M | ||